Virtu Financial’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-28,713
Closed -$104K 2483
2021
Q3
$104K Buy
+28,713
New +$108K 0.01% 1139
2021
Q1
Sell
-16,593
Closed -$70K 2383
2020
Q4
$70K Buy
+16,593
New +$63.9K 0.01% 1153
2019
Q2
Sell
-56,674
Closed -$300K 2107
2019
Q1
$300K Buy
+56,674
New +$259K 0.02% 794
2018
Q4
Sell
-48,820
Closed -$137K 2253
2018
Q3
$137K Buy
48,820
+10,312
+27% +$28.9K 0.01% 1148
2018
Q2
$113K Sell
38,508
-8,692
-18% -$20.6K 0.01% 1629
2018
Q1
$106K Buy
47,200
+1,251
+3% +$2.93K 0.01% 1568
2017
Q4
$136K Buy
45,949
+19,348
+73% +$53.5K 0.01% 1821
2017
Q3
$78K Buy
+26,601
New +$81K ﹤0.01% 2133

Other funds holding BDSI

Virtu Financial's BDSI Position: Q4 2021 in Review

Virtu Financial sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2021, closing a stake of 28,713 shares — an estimated $104K sold.

Virtu Financial first reported a position in BDSI in Q3 2017 and held it in 8 quarters. The position peaked at $300K in Q1 2019. 156 funds tracked by Wall St. Rank hold BDSI as of Q4 2021.

  • Virtu Financial reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2021 after selling out during the quarter.
  • Virtu Financial sold 28,713 BioDelivery Sciences International, Inc. shares in Q4 2021, an estimated $104K.
  • Virtu Financial first reported a position in BioDelivery Sciences International, Inc. in Q3 2017 and held it in 8 quarters.
  • Virtu Financial's BioDelivery Sciences International, Inc. position peaked at $300K in Q1 2019.
  • 156 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2021.

Based on Virtu Financial's 13F filing for Q4 2021, filed 17 Feb 2022.